Skip to main content
SPRC
NASDAQ Life Sciences

SciSparc Files $50M Universal Shelf Registration Amidst Nasdaq Compliance Concerns

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
9
Price
$0.755
Mkt Cap
$3.282M
52W Low
$0.71
52W High
$12.138
Market data snapshot near publication time

summarizeSummary

SciSparc Ltd. has filed a universal shelf registration statement to offer up to $50 million in various securities, a substantial amount relative to its current market capitalization, indicating a significant need for future capital raises.


check_boxKey Events

  • Universal Shelf Registration Filed

    SciSparc registered to offer up to $50 million in ordinary shares, warrants, or units, providing a mechanism for future capital raises.

  • Significant Dilution Potential

    The $50 million authorization is approximately 15 times the company's current market capitalization, indicating a high potential for future dilution for existing shareholders.

  • Context of Financial Distress

    This filing follows a recent Nasdaq non-compliance notice for minimum stockholders' equity on January 12, 2026, and a prior dilutive offering on January 14, 2026, underscoring the company's urgent need for capital.

  • Capital for Operations

    Proceeds are intended for working capital, research and development, and general corporate purposes, which are crucial for the company's ongoing operations and strategic initiatives.


auto_awesomeAnalysis

This F-3 filing establishes a mechanism for SciSparc to raise up to $50 million through the sale of ordinary shares, warrants, or units. Given the company's current market capitalization and recent Nasdaq non-compliance for minimum stockholders' equity, this registration highlights a critical need for capital. While the company is limited by public float rules to sell no more than one-third of its public float in any 12-month period, the sheer size of the authorized shelf facility creates a substantial overhang and signals a high potential for future dilution. This follows a recent registered direct offering in January and a Nasdaq delisting notice, underscoring the company's ongoing financial challenges and the necessity of this capital raise for operational continuity and compliance.

At the time of this filing, SPRC was trading at $0.75 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.3M. The 52-week trading range was $0.71 to $12.14. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed SPRC - Latest Insights

SPRC
Apr 29, 2026, 4:20 PM EDT
Filing Type: 20-F
Importance Score:
9
SPRC
Mar 16, 2026, 8:21 AM EDT
Source: Reuters
Importance Score:
7
SPRC
Mar 12, 2026, 4:41 PM EDT
Filing Type: 6-K
Importance Score:
8
SPRC
Mar 12, 2026, 7:55 AM EDT
Source: GlobeNewswire
Importance Score:
7
SPRC
Mar 10, 2026, 9:28 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
SPRC
Mar 02, 2026, 8:08 AM EST
Filing Type: 6-K
Importance Score:
9
SPRC
Feb 17, 2026, 5:27 PM EST
Filing Type: F-3
Importance Score:
9
SPRC
Feb 17, 2026, 4:01 PM EST
Filing Type: 6-K
Importance Score:
9
SPRC
Feb 12, 2026, 4:02 PM EST
Filing Type: 6-K
Importance Score:
9
SPRC
Feb 03, 2026, 4:36 PM EST
Filing Type: F-3
Importance Score:
9